Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal(Michael E. DeBakey VA Medical Center), Hashem B. El‐Serag(Baylor College of Medicine), Yamini Natarajan, Jinna Chu(Michael E. DeBakey VA Medical Center), Roxanne Desiderio, Steven M. Asch(RAND Corporation), Jennifer R. Kramer(Michael E. DeBakey VA Medical Center), Srikar Mapakshi(Michael E. DeBakey VA Medical Center), Liang Li(Tongji University), Maneerat Chayanupatkul(Chulalongkorn University), Peter Richardson(Michael E. DeBakey VA Medical Center), Aaron P. Thrift
Cited by 796
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
|Gastroenterology|2022|1.2k
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
|Gastroenterology|2017|929
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789